MyAverix Finance
NS · Pharmaceuticals
Valiant Laboratories Ltd (VALIANTLAB)
Pharmaceuticals & Biotechnology
Valiant Laboratories Ltd (VALIANTLAB) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $3.70B, P/E ratio is 66.76, net margin is 0.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for VALIANTLAB
Valiant Laboratories Ltd (VALIANTLAB) — FAQ
What is Valiant Laboratories Ltd's market cap?
Valiant Laboratories Ltd (VALIANTLAB) has a reported market cap of $3.70B (data as of 2026-07-10).
What is VALIANTLAB's P/E ratio?
The price-to-earnings (P/E) ratio for Valiant Laboratories Ltd (VALIANTLAB) is 66.76 (data as of 2026-07-10).
Does Valiant Laboratories Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Valiant Laboratories Ltd (VALIANTLAB). Check the MyAverix Finance app for the latest dividend data.
What sector is Valiant Laboratories Ltd in?
Valiant Laboratories Ltd (VALIANTLAB) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is VALIANTLAB listed on?
VALIANTLAB is listed on NS.
What is Valiant Laboratories Ltd's net margin?
Valiant Laboratories Ltd (VALIANTLAB) reports a net margin of 0.4% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.